Literature DB >> 24162730

Subtypes of hypertension and risk of stroke in rural Chinese adults.

Zhaoqing Sun1, Xiaodan Han, Liqiang Zheng, Xingang Zhang, Jue Li, Dayi Hu, Yingxian Sun.   

Abstract

BACKGROUND: Hypertension is a definitive risk factor for stroke. We examined the associations between hypertension subtypes and stroke incidence in rural Chinese adults.
METHODS: We conducted a prospective study in a sample of 38,949 rural Chinese adults aged ≥35 years and free from stroke at baseline. The subtypes of hypertension were defined as isolated systolic hypertension (ISH), isolated diastolic hypertension (IDH), systolic and diastolic hypertension (SDH), and managed hypertension (MHT). The relative risks of stroke with the subtypes of hypertension, compared with normotensive subjects, were estimated using the Cox model after adjusting for age, sex, and other confounders.
RESULTS: The prevalence of hypertension was as follows: SDH = 18.6%, ISH = 10.2%, IDH = 5.8%, and MHT = 0.4%. During a total of 168,023 person-years of follow-up, 858 subjects developed stroke. The incidence rate per 100,000 person-years of overall first-ever stroke was 510.6. The SDH group was at the highest risk of stroke among all the hypertensive subjects. The hazard ratio was 2.13 (95% confidence interval (CI) = 1.78-2.55) for all stroke, 2.74 (95% CI = 2.08-3.60) for hemorrhagic stroke, and 1.92 (95% CI = 1.50-2.45) for ischemic stroke.
CONCLUSIONS: SDH patients warrant the most attention for prevent of stroke. However, ISH and IDH are also independent predictors of stroke. The risk factors for stroke, especially hypertension, were not controlled in the rural population we studied. More aggressive efforts to control the risk factors for stroke in rural areas are needed.

Entities:  

Keywords:  China; blood pressure; epidemiology; hypertension; rural population; stroke.

Mesh:

Year:  2013        PMID: 24162730     DOI: 10.1093/ajh/hpt197

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  6 in total

1.  Prevalence, awareness, treatment and control of high blood pressure among Chinese rural population in Haimen, Jiangsu.

Authors:  T Li; Y Xian; H-M Mao; W-J Jiang; L Zhang; E P F Chow; J-P Huang; Y-H Lu; T Tian; S-Y Jiang; X Zhuang
Journal:  J Hum Hypertens       Date:  2015-10-22       Impact factor: 3.012

2.  Financing strategies to improve essential public health equalization and its effects in China.

Authors:  Li Yang; Li Sun; Liankui Wen; Huyang Zhang; Chenyang Li; Kara Hanson; Hai Fang
Journal:  Int J Equity Health       Date:  2016-12-01

3.  Prevalence, Awareness, and Treatment of Isolated Diastolic Hypertension: Insights From the China PEACE Million Persons Project.

Authors:  Shiwani Mahajan; Danwei Zhang; Siyun He; Yuan Lu; Aakriti Gupta; Erica S Spatz; Jiapeng Lu; Chenxi Huang; Jeph Herrin; Shuling Liu; Jingwei Yang; Chaoqun Wu; Jianlan Cui; Qiuli Zhang; Xi Li; Khurram Nasir; Xin Zheng; Harlan M Krumholz; Jing Li
Journal:  J Am Heart Assoc       Date:  2019-09-28       Impact factor: 5.501

4.  Isolated Diastolic Hypertension and Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis of Cohort Studies With 489,814 Participants.

Authors:  Mingyan Huang; Linzi Long; Ling Tan; Aling Shen; Mi Deng; Yuxuan Peng; Wenwen Yang; Hongzheng Li; Yue Wei; Meng Li; Feifei Liao; Chao Liu; Aimei Lu; Hua Qu; Changgeng Fu; Keji Chen
Journal:  Front Cardiovasc Med       Date:  2022-01-05

5.  Cumulative exposure to elevated blood pressure better predicts cardiovascular disease risk in rural Chinese adults.

Authors:  Jiangbo Wang; Shiru Zhang; Yundi Jiao; Liqiang Zheng; Yingxian Sun; Zhaoqing Sun
Journal:  Front Public Health       Date:  2022-10-04

6.  The different associations between platelet distribution width and hypertension subtypes in males and females.

Authors:  Tingwei Li; Jiahui Jin; Zhaowei Meng; Wenjuan Zhang; Yongle Li; Xuefang Yu; Xin Du; Ming Liu; Qing Zhang; Ying Gao; Kun Song; Xing Wang; Yaguang Fan; Yan Wang
Journal:  Biosci Rep       Date:  2020-11-27       Impact factor: 3.840

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.